Pharmaceutical

AstraZeneca posts 81% rise in FY 2023 profit after tax

AstraZeneca has reported a significant 81% rise in profit after tax, reaching $5.96bn for FY 2023 from $3.29bn in the previous year.

Feb 10, 2024 - 18:00
AstraZeneca posts 81% rise in FY 2023 profit after tax
AstraZeneca has reported a significant 81% rise in profit after tax, reaching $5.96bn for FY 2023 from $3.29bn in the previous year.
Read the original article

Tags:

Previous Article

Boehringer and CBmed partner to develop cancer therapies

Next Article

BioNTech partners with Autolus to advance CAR-T therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch

STAT+: Pharmalittle: Novo Nordisk spent $11 million on ...

Jul 6, 2023

Health care negotiations on Capitol Hill are clear as mud

Health care negotiations on Capitol Hill are clear as mud

Jan 16, 2024

STAT+: Workforce, capacity constraints slow ramp-up of new Alzheimer’s drug Leqembi

STAT+: Workforce, capacity constraints slow ramp-up of ...

Aug 31, 2023